EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

DocGo Inc (DCGO) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of DocGo Inc $0.54, price $0.34, upside +57.9%, quality 58 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN US2560861096

DI DocGo Inc logo Thin data Sep 23, 2026

DocGo Inc

DCGO · US

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value $0.5368 · Strongly undervalued (+58%)
!Quality 58/100
!Weak Growth (revenue 5y +27.9 %/yr)
!Loss-making · -62.2% net margin (TTM)
✓Low debt · generates free cash flow
!Mixed vs. peers (6/11)
!Narrow moat 6/100
!Evidence only low, so the estimate is less certain
Watch DocGo Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$11.10 $0.3400 Fair Value $0.5368 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.3400 – $11.10 · fair‑value band $0.3787 – $0.7357 · the $0.3400 price screens below the $0.5368 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow DocGo in your weekly email

Every Wednesday you see whether DocGo is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments.

Show more

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Stock analysis

DocGo Inc (DCGO) currently trades at $0.3400, while our model-based Fair Value estimate is $0.5368, implying the stock looks roughly 36.7% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $4.51 per share, and 7 of the 7 models we run sit above the $0.3400 price.

Bear case: the Asset-Based group reads lowest at $0.9800, and 0 of the 7 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.3787 (bear) to $0.7357 (bull), the price of $0.3400 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

DocGo Inc reported revenue of $322M in FY2025 versus $319M in FY2021, a compound +0.3%/yr. Reported net income was −$182M in FY2025.

Key figures

Market cap $51.7M · P/S ratio 0.17 · EPS (TTM) $−1.90 · Net margin −56.6% · Return on equity −97.8% · Return on assets (EBIT) −4.2% · Operating margin −24.8% · Revenue (TTM) $302M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 77% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at 58%, DCGO screens cheaper than that median.

Fair Value models

Bear $0.3787 Fair Value $0.5368 Bull $0.7357
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $3.09 $4.51 $6.52 78
Growth DCF $3.05 $4.29 $5.93 76
5Y Revenue Exit $2.98 $4.61 $6.77 70
All 7 models by family
DCF Models
FCF DCF $3.09 $4.51 $6.52 78
5Y Revenue Exit $2.98 $4.61 $6.77 70
10Y Revenue Exit $2.92 $4.33 $6.38 64
Multiples
EV/Revenue $3.00 $4.07 $5.14 54
Asset-Based
NCAV (Graham) $0.7300 $0.9800 $1.46 54
Growth DCF
Growth DCF $3.05 $4.29 $5.93 76
Rev-Margin DCF $2.98 $4.59 $6.63 70

Open the full fair value analysis →

Notify me when DCGO reaches fair value

Put DCGO on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 58/100

Of which business quality 60 · Market factors (momentum, volatility) 12

Profitability 37
Margins and returns on capital today
Quality Growth 22
Are margins and returns improving?
Cashflow 54
Earnings quality: real cash, not paper profit
Fin. Strength 70
Balance sheet, leverage, solvency risk
Investment 99
Disciplined investing over empire-building
Low Volatility 31
Calm price path (market factor)
Momentum 6
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 98
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−47.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.9%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+37.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−15.7% (2020) → −27.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch DCGO, get fair value alerts →

Compare DocGo Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks

Beats the industry median on 6/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside +58% · Top 25%
Profitability
Return on assets −18% · Bottom 25%
Net margin (TTM) −62% · Bottom 25%
Operating margin (TTM) −25% · Bottom 25%
Growth and dividend
Revenue growth −21% · Bottom 25%
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 0.36× · Cheapest 25%
P/S (TTM) 0.17× · Cheapest 25%
P/FCF 1.9× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 33
FUTURE (revenue growth)0 · sector 28
PAST (return on equity)0 · sector 31
HEALTH (low debt)100 · sector 89
DIVIDEND (yield)0 · sector 43

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $436.48 $592.64 +36%
Fresenius SE FRE €45.74 €34.54 −24%
Dr. Sulaiman Al Habib Medical Services Group 4013 227.50 SAR 109.45 SAR −52%
IHH Healthcare Berhad, an investment holding company, 5225 8.00 MYR 4.87 MYR −39%
Tenet Healthcare Corporation THC $256.44 $399.58 +56%
DaVita Inc DVA $183.14 $255.97 +40%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹9,069 ₹2,908 −68%
Fresenius Medical Care AG FMS $22.41 $45.58 +103%
Aier Eye Hospital Group 300015 ¥8.07 ¥10.86 +35%
Encompass Health Corporation EHC $122.76 $96.51 −21%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

DocGo Inc · Fair Value
$0.5368 +37%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "DocGo Inc Fair Value". https://www.fairvalue-calculator.com/stock/DCGO

Frequently asked questions

Is DocGo Inc (DCGO) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.5368 versus a price of $0.3400, about +58% upside (undervalued).
What is the fair value of DCGO?
Our model-based fair value for DocGo Inc is $0.5368 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.3400.
What is the quality score of DCGO?
DocGo Inc has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for DocGo Inc (DCGO)?
Our model-based price target is the fair value of $0.5368 (as of Sep 23, 2026) from 7 valuation models. Cautious scenario $0.3787, optimistic scenario $0.7357. It is a calculation from audited fundamentals, not an analyst target.
What is the DocGo Inc stock forecast for 2026?
Our models put fair value at $0.5368, about +58% upside versus a price of $0.3400 (undervalued). Cautious scenario $0.3787, optimistic scenario $0.7357. The calculation is refreshed regularly with new filings.
What is the revenue of DocGo Inc (DCGO)?
DocGo Inc reported trailing-twelve-month revenue of about $302M (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of DocGo Inc (DCGO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For DocGo Inc it is $0.5368 per share (as of Sep 23, 2026), against a price of $0.3400. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is DocGo Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, DCGO trades below its calculated fair value: price $0.3400, fair value $0.5368, a gap of about +58% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DCGO?
No. The price is what the market pays today ($0.3400); the fair value is what the company's own numbers justify ($0.5368). For DocGo Inc the two are $0.1968 per share apart. That gap is exactly why we show both numbers side by side.
How much is DocGo Inc worth?
The market values DocGo Inc at about $51.7M (market capitalisation, as of Sep 23, 2026). Per share that is $0.3400; our models calculate a fair value of $0.5368 per share.
What do the bullish and bearish scenarios say about DCGO?
Our models span a range for DocGo Inc: cautious scenario $0.3787, base $0.5368, optimistic $0.7357 per share (as of Sep 23, 2026, price $0.3400). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of DocGo Inc (DCGO)?
Balance-sheet figures for DocGo Inc (as of Sep 23, 2026): return on equity −97.8%, debt of 0.00 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is DCGO from its 52-week high?
DocGo Inc trades at $0.3400, about 77% below its 52-week high of $1.49 and at the low of $0.3400 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5368 is for.
Which stocks are comparable to DocGo Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is DocGo Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $0.3400, calculated fair value $0.5368 (+58%), Quality Score 58/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DCGO calculated?
We run DocGo Inc through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.5368, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. DocGo Inc currently trades 58 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of DocGo Inc (DCGO)?
The closing price on Sep 24, 2026 was $0.3400. Our model-based fair value is $0.5368, about +58% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with DocGo Inc right now?
The price is below even our cautious bear case ($0.3787). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($0.3787 to $0.7357) leaves room in how you read the outcome.

Key figures of DocGo Inc

How large is the market capitalisation of DocGo Inc (DCGO)?
The market capitalisation of DocGo Inc is $51.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of DocGo Inc (DCGO)?
The price-to-sales ratio of DocGo Inc is 0.17 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of DocGo Inc (DCGO)?
Earnings per share at DocGo Inc are $−1.90. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of DocGo Inc (DCGO)?
The net margin of DocGo Inc is −56.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of DocGo Inc (DCGO)?
The return on equity (ROE) of DocGo Inc is −97.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of DocGo Inc (DCGO)?
On an EBIT basis the return on assets of DocGo Inc is −4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of DocGo Inc (DCGO)?
The operating margin of DocGo Inc is −24.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at DocGo Inc (DCGO)?
Revenue at DocGo Inc is growing −21.3% versus a year earlier (3y avg −9.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at DocGo Inc (DCGO)?
Earnings per share at DocGo Inc are growing +9.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does DocGo Inc (DCGO) generate?
The free cash flow of DocGo Inc is $27.0M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does DocGo Inc (DCGO) hold?
DocGo Inc holds more cash than debt, $21.8M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch DocGo Inc in the live analysis

One click puts DocGo Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.